AKT1 and breast cancer: The PI3K/Akt/mTOR pathway is dysfunctional in many tumors, promoting the biological processes of proliferation, invasion and evasion of cell death (Miricescu et al., 2021), but drug resistance in breast cancer (Dong et al., 2021).